Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1976 Jun;3(3 Suppl 2):401–403. doi: 10.1111/j.1365-2125.1976.tb03733.x

Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.

H A McClelland
PMCID: PMC1428828  PMID: 9966

Full text

PDF
401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AYD F. J., Jr A survey of drug-induced extrapyramidal reactions. JAMA. 1961 Mar 25;175:1054–1060. doi: 10.1001/jama.1961.03040120016004. [DOI] [PubMed] [Google Scholar]
  2. Chien C. P., Dimascio A., Cole J. O. Antiparkinsonian agents and depot phenothiazine. Am J Psychiatry. 1974 Jan;131(1):86–90. doi: 10.1176/ajp.131.1.86. [DOI] [PubMed] [Google Scholar]
  3. Gerlach J., Reisby N., Randrup A. Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia. 1974 Jan 9;34(1):21–35. doi: 10.1007/BF00421217. [DOI] [PubMed] [Google Scholar]
  4. Johnson D. A. Observations on the dose regime of fluphenazine decanoate in maintenance therapy ofschizophrenia. Br J Psychiatry. 1975 May;126:457–461. doi: 10.1192/bjp.126.5.457. [DOI] [PubMed] [Google Scholar]
  5. Johnson D. A. The side-effects of fluphenazine decanoate. Br J Psychiatry. 1973 Nov;123(576):519–522. doi: 10.1192/bjp.123.5.519. [DOI] [PubMed] [Google Scholar]
  6. Kazamatsuri H., Chien C., Cole J. O. Therapeutic approaches to tardive dyskinesia. A review of the literature. Arch Gen Psychiatry. 1972 Oct;27(4):491–499. doi: 10.1001/archpsyc.1972.01750280059011. [DOI] [PubMed] [Google Scholar]
  7. Kennedy P. F., Hershon H. I., McGuire R. J. Extrapyramidal disorders after prolonged phenothiazine therapy. Br J Psychiatry. 1971 May;118(546):509–518. doi: 10.1192/bjp.118.546.509. [DOI] [PubMed] [Google Scholar]
  8. Klett C. J., Caffey E., Jr Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics. Arch Gen Psychiatry. 1972 Apr;26(4):374–379. doi: 10.1001/archpsyc.1972.01750220084016. [DOI] [PubMed] [Google Scholar]
  9. McClelland H. A., Blessed G., Bhate S., Ali N., Clarke P. A. The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients. Br J Psychiatry. 1974 Feb;124(579):151–159. doi: 10.1192/bjp.124.2.151. [DOI] [PubMed] [Google Scholar]
  10. Mindham R. H., Gaind R., Anstee B. H., Rimmer L. Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism. Psychol Med. 1972 Nov;2(4):406–413. doi: 10.1017/s0033291700045220. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES